Pharmability AB
PrivateLast Round
Early Funding
Apr 9, 2025
Total Funding Raised
$5.66M
Company Overview
Pharmability AB is a biotechnology company developing next-generation immunomodulatory therapies for autoimmune skin diseases, with an initial focus on atopic dermatitis.
Sector
Healthcare & Life Sciences
Verticals
Compliance & Risk, Quality Management, Biotechnology, Medical Devices, RegTech
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pharmability AB Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Pharmability AB Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Apr 9, 2025 | ||||
| Grant | Aug 1, 2024 | ||||
| Early Funding | Nov 20, 2020 |
Key People
Founding team and executive leadership
Pharmability AB Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Almi Invest AB | Early Funding |
| Vinnova | Grant |
| Sciety | Early Funding |
| Swelife | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 18, 2025
Partnered with Bachem Americas, Inc. for atopic dermatitis therapy.
- Nov 6, 2025
Strengthening collaboration with Zelmic AB.
Pharmability AB Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pharmability AB's valuation, stock price, and market status.